Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Nov 14, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001973141-23-000294.pdf
Nov 14, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000040.pdf 0001968202-23-000040.xls
Nov 08, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000039.pdf 0001968202-23-000039.xls
Nov 07, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001968582-23-000623.pdf
Nov 02, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0001804220-23-000029.pdf 0001804220-23-000029.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 02, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001804220-23-000031v2.pdf 1.2 MB 0001804220-23-000031.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 02, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000079.pdf 0001883850-23-000079.xls
Nov 01, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-004676.pdf 0001950047-23-004676.xls
Oct 17, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000037.pdf 0001968202-23-000037.xls
Oct 13, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001973141-23-000242.pdf

Data provided by Kaleidoscope.

Investors & Media